The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
The Epidemiology of Sepsis in the United States from 1979 through 2000
Open accessAbstract
BACKGROUND: Sepsis represents a substantial health care burden, and there is limited epidemiologic information about the demography of sepsis or about the temporal changes in its incidence and outcome. We investigated the epidemiology of sepsis in the United States, with specific examination of race and sex, causative organisms, the disposition of patients, and the incidence and outcome. METHODS: We analyzed the occurrence of sepsis from 1979 through 2000 using a nationally representative sample of all nonfederal acute care hospitals in the United States. Data on new cases were obtained from hospital discharge records coded according to the International Classification of Diseases, Ninth Revision, Clinical Modification. RESULTS: Review of discharge data on approximately 750 million hospitalizations in the United States over the 22-year period identified 10,319,418 cases of sepsis. Sepsis was more common among men than among women (mean annual relative risk, 1.28 [95 percent confidence interval, 1.24 to 1.32]) and among nonwhite persons than among white persons (mean annual relative risk, 1.90 [95 percent confidence interval, 1.81 to 2.00]). Between 1979 and 2000, there was an annualized increase in the incidence of sepsis of 8.7 percent, from about 164,000 cases (82.7 per 100,000 population) to nearly 660,000 cases (240.4 per 100,000 population). The rate of sepsis due to fungal organisms increased by 207 percent, with gram-positive bacteria becoming the predominant pathogens after 1987. The total in-hospital mortality rate fell from 27.8 percent during the period from 1979 through 1984 to 17.9 percent during the period from 1995 through 2000, yet the total number of deaths continued to increase. Mortality was highest among black men. Organ failure contributed cumulatively to mortality, with temporal improvements in survival among patients with fewer than three failing organs. The average length of the hospital stay decreased, and the rate of discharge to nonacute care medical facilities increased. CONCLUSIONS: The incidence of sepsis and the number of sepsis-related deaths are increasing, although the overall mortality rate among patients with sepsis is declining. There are also disparities among races and between men and women in the incidence of sepsis. Gram-positive bacteria and fungal organisms are increasingly common causes of sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This approach follows the methods validated by many studies on the epidemiology of sepsis26, 27, 28, 29 and was used by Rudd and colleagues.10”
From Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 (2024) · cites this paper as [28]
In the citing paper
“This trend continued with a greater than 200% increase from 1979 to 2000.23”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [23]
In the citing paper
“McNeil et al. (154) published an analysis of trends in infectious disease mortality in the United States and found a dramatic increase in multiple-cause mortality due to mycoses, from 1,557 deaths in 1980 to 6,534 deaths in 1997; the majority of these mycoses-related deaths were associated with Candida , Aspergillus , and Cryptococcus sp. infection.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“At the same time, they showed an almost exponential increase in the mortality rates associated with IA, with a 357% increase in mortality between 1980 and 1996.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“Previously, McNeil et al. (154) demonstrated that mortality rates associated with IC increased steadily from 1980 to a peak in 1989, followed by a gradual decline through 1996.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“These data are directly comparable to those of McNeil et al. (154) and extend the data reported in that study beyond 1996 to the year 2003.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“Again, the limitations of such data are well known, most notably the lack of validation of the mycotic infection and the failure to clinically diagnose IA and IC, resulting in an underestimation of mortality (154).”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“As stated by McNeil and colleagues (154), mortality associated with invasive mycoses is best represented by multiplecause-of-death data, which capture any mention of the mycotic disease on the death certificate.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“Although this approach provides a much more generalizable sample of U.S. hospitals than many other methods of surveillance, it is likely to underestimate both incidence and mortality because of miscoding of IC, use of codes not captured by the analysis, or failure to code the infection at all (79, 154).”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J., Laterre, P., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,124
Rising Incidence of Hepatocellular Carcinoma in the United States
El‐Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,865
The Natural History of the Systemic Inflammatory Response Syndrome (SIRS)
Rangel-Frausto, M. S., Pittet, D., Costigan, M., Hwang, T., Davis, C. S., & Wenzel, R. P. (1995) · JAMA · doi:10.1001/jama.273.2.117 · Cited by 2,090
High-Dose Antithrombin III in Severe Sepsis
Warren, B., Eid, A. A., Singer, P., Pillay, S., Carl, P., Novák, I., Chalupa, P., Atherstone, A., Pénzes, I., Kübler, A., et al. (2001) · JAMA · doi:10.1001/jama.286.15.1869 · Cited by 1,422
Parrillo, J. E., Parker, M. M., Natanson, C., Suffredini, A. F., Danner, R. L., Cunnion, R. E., & Ognibene, F. P. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-227 · Cited by 1,188
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults
Brun‐Buisson, C. (1995) · JAMA · doi:10.1001/jama.274.12.968 · Cited by 1,079
Treating Patients with Severe Sepsis
Wheeler, A. P., & Bernard, G. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400307 · Cited by 992
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- 1990, MMWR Morb Mortal Wkly Rep, 39, 31
- Eaton S, 2002, Am J Respir Crit Care Med, 165, A471
Cited by
Sorted by citations
Items 1,001–1,032 of 1,032
Luiking, Y. C., Poeze, M., & Deutz, N. E. (2015) · Clinical Science · doi:10.1042/cs20140343 · Cited by 78
Guerrero, J., Gatica, H. A., Rodríguez, M., Estay, R., & Goecke, I. A. (2013) · Critical Care · doi:10.1186/cc12774 · Cited by 71
Occurrence, presentation and treatment of candidemia
Mikulska, M., Del Bono, V., Ratto, S., & Viscoli, C. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.52 · Cited by 71
Gruther, W., Pieber, K., Steiner, I., Hein, C., Hiesmayr, J. M., & Paternostro-Sluga, T. (2017) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000000718 · Cited by 70
Ryoo, S. M., Kim, W. Y., Sohn, C. H., Seo, D. W., Oh, B. J., Lim, K. S., & Koh, J. W. (2015) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000423 · Cited by 62
Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting
Lepak, A., & Andes, D. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2010.11.001 · Cited by 62
Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans
Ahn, S. H., Tsalik, E. L., Cyr, D. D., Zhang, Y., van Velkinburgh, J. C., Langley, R. J., Glickman, S. W., Cairns, C. B., Zaas, A. K., Rivers, E. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0048979 · Cited by 61
Changes in CRH and ACTH Synthesis during Experimental and Human Septic Shock
Polito, A., Sonneville, R., Guidoux, C., Barrett, L., Viltart, O., Mattot, V., Siami, S., Lorin de la Grandmaison, G., Chrétien, F., Singer, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025905 · Cited by 55
Kamiyama, K., Matsuda, N., Yamamoto, S., Takano, K.-I., Takano, Y., Yamazaki, H., Kageyama, S.-I., Yokoo, H., Nagata, T., Hatakeyama, N., et al. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00459.2007 · Cited by 53
Chelkeba, L., Ahmadi, A., Abdollahi, M., Najafi, A., Ghadimi, M. H., Mosaed, R., & Mojtahedzadeh, M. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0071-y · Cited by 51
Brown, S. M., Jones, J., Kuttler, K. G., Keddington, R. K., Allen, T. L., & Haug, P. (2016) · BMC Emergency Medicine · doi:10.1186/s12873-016-0095-0 · Cited by 45
Systemic inflammation induced the delayed reduction of excitatory synapses in the CA3 during ageing
Manabe, T., Rácz, I., Schwartz, S., Oberle, L., Santarelli, F., Emmrich, J. V., Neher, J. J., & Heneka, M. T. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15491 · Cited by 44
Use of explicit ICD9-CM codes to identify adult severe sepsis: impacts on epidemiological estimates
Bouza, C., Lopez-Cuadrado, T., & Amate-Blanco, J. M. (2016) · Critical Care · doi:10.1186/s13054-016-1497-9 · Cited by 47
Diabetes mellitus and community-acquired bloodstream infections in the critically ill
McKane, C. K., Marmarelis, M., Mendu, M. L., Moromizato, T., Gibbons, F. K., & Christopher, K. B. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2013.08.019 · Cited by 46
Time to antibiotics and the outcome of patients with septic shock: A propensity score analysis.
Ko, B. S., Choi, S.-H., Kang, G. H., Shin, T. G., Kim, K., Jo, Y. H., Ryoo, S. M., Kim, Y.-J., Park, Y. S., Kwon, W. Y., et al. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.09.012 · Cited by 42
Zilberberg, M. D., & Shorr, A. F. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.04.008 · Cited by 42
Zhong, X., Xie, L., Yang, X., Liang, F., Yang, Y., Tong, J., Zhong, Y., Zhao, K., Tang, Y., & Yuan, C. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00181-3 · Cited by 42
Sepsis-induced alterations in sleep of rats
Baracchi, F., Ingiosi, A. M., Raymond, R. M., & Opp, M. R. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00354.2011 · Cited by 42
Sepsis and Acute Kidney Injury
Bilgili, B., Haliloglu, M., & Cinel, I. (2014) · Turkish Journal of Anesthesia and Reanimation · doi:10.5152/tjar.2014.83436 · Cited by 42
Hepatic Hepcidin Protects against Polymicrobial Sepsis in Mice by Regulating Host Iron Status
Zeng, C., Chen, Q., Zhang, K., Chen, Q., Song, S., & Fang, X. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000466 · Cited by 37
Cauwels, A., & Brouckaert, P. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq317 · Cited by 39
Effective Treatment of Mouse Sepsis With an Inhibitory Antibody Targeting Integrin αvβ5*
Su, G., Atakilit, A., Li, J. T., Wu, N., Luong, J., Chen, R., Bhattacharya, M., & Sheppard, D. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182711b1e · Cited by 36
Low-dose PLX5622 treatment prevents neuroinflammatory and neurocognitive sequelae after sepsis
Mein, N., von Stackelberg, N., Wickel, J., Geis, C., & Chung, H.-Y. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02975-8 · Cited by 36
Spanakis, E. K., Kourkoumpetis, T. K., Livanis, G., Peleg, A. Y., & Mylonakis, E. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0447 · Cited by 31
Buss, N. A. P. S., Gavins, F. N. E., Cover, P. O., Terron, A., & Buckingham, J. C. (2015) · The FASEB Journal · doi:10.1096/fj.14-268375 · Cited by 23
An evaluation of sepsis Web sites for patient and family education.
Oermann, M. H., & McInerney, S. M. (2007) · Plastic Surgical Nursing · doi:10.1097/01.psn.0000306184.95812.8a · Cited by 20
Enhancing sepsis management through machine learning techniques: A review
Ocampo-Quintero, N., Vidal-Cortés, P., del Río Carbajo, L., Fdez-Riverola, F., Reboiro-Jato, M., & Glez-Peña, D. (2022) · Medicina Intensiva · doi:10.1016/j.medin.2020.04.003 · Cited by 20
Anderson, D. J., Moehring, R. W., Parish, A., David, M. Z., Hsueh, K., Cressman, L., Tolomeo, P., Habrock-Bach, T., Hill, C. L., Ryan, M., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab937 · Cited by 19
Antifungal prophylaxis and pre-emptive therapy
Viscoli, C. (2009) · Drugs · doi:10.2165/11315540-000000000-00000 · Cited by 18
Hviid, C. V. B., Samulin Erdem, J., Drechsler, S., Weixelbaumer, K., Ahmed, M. S., Attramadal, H., Redl, H., Bahrami, S., Osuchowski, M. F., & Aasen, A. O. (2014) · Shock · doi:10.1097/shk.0000000000000105 · Cited by 15
Zhang, X., Li, S., Luo, H., He, S., Yang, H., Li, L., Tian, T., Han, Q., Ye, J., Huang, C., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01035-6 · Cited by 14
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0000298158.12101.41 · Cited by 9
Metadata
- Authors
- Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M.
- Affiliations
- Emory University (US)
- Centers for Disease Control and Prevention (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-17
- Volume
- 348
- Issue
- 16
- Pages
- 1546-1554
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2145577370
- Cited by
- 5,841
- References
- 48
- Citations by year
- 2026: 67 · 2025: 128 · 2024: 149 · 2023: 168 · 2022: 167 · 2021: 253 · 2020: 231 · 2019: 211 · 2018: 226 · 2017: 329 · 2016: 292 · 2015: 341 · 2014: 381 · 2013: 436 · 2012: 365
- FWCI
- 123.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA R01-11660, R01AA011660)
- National Heart, Lung, and Blood Institute (K23HL067739, HL K23-67739)
- National Center for Research Resources (L30 RR020488)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- PSIS, sepsis incidence, sepsis mortality, temporal trends, racial disparities, sex differences, Gram-positive bacteria, fungal infection, sepsis pathogens, organ failure, length of hospital stay, hospital discharge disposition, Black men, hospital discharge data, acute care hospitals, healthcare burden
- MeSH terms
- Female, Humans, Male, Middle Aged, Multiple Organ Failure, Sex Factors, United States, Incidence, Survival Rate, Hospital Mortality, Sepsis, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
